Cytogenetic features in primary myelodysplastic syndrome Egyptian patients

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients

Karyotype is the most important diagnostic and prognostic parameter in myelodysplastic syndromes (MDS) and is abnormal in approximately 50% of patients. We emphasized the importance of chromosomal analysis and reported the most frequent cytogenetic abnormalities in 50 MDS (29 males (58%) and 21 fema...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Yasser Elnahass, Lamiaa Youssif
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Elsevier 2018-03-01
Reeks:	Journal of Advanced Research
Onderwerpen:	MDS Gender Chromosomal abnormalities −5/5q- MDS-MLD MDS-EB-II
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2090123218300225

Gelijkaardige items

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
door: Minh Phuong Vu, et al.
Gepubliceerd in: (2022-01-01)

DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES
door: Prof. Giuseppe Leone, et al.
Gepubliceerd in: (2022-04-01)

Clinical biological features of mixed myeloiddiseases
door: S V Gritsaev, et al.
Gepubliceerd in: (2004-12-01)

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
door: Michele Stanchina, et al.
Gepubliceerd in: (2021-04-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
door: Muneshwar Kumar, et al.
Gepubliceerd in: (2019-06-01)

Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
door: Narayanan S
Gepubliceerd in: (2017-02-01)

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes
door: Miroslav Pribyl, et al.
Gepubliceerd in: (2020-10-01)

CLINICO-PATHOLOGICAL SPECTRUM AND NOVEL KARYOTYPIC FINDINGS IN MYELODYSPLASTIC SYNDROME: EXPERIENCE OF TERTIARY CARE CENTRE IN INDIA.
door: Ruchi Gupta, et al.
Gepubliceerd in: (2017-08-01)

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview
door: Andrea Kuendgen, et al.
Gepubliceerd in: (2021-11-01)

Autoimmune syndromes presenting as a paraneoplastic manifestation of myelodysplastic syndromes: clinical features, course, treatment and outcome
door: Bradley T. Williamson, et al.
Gepubliceerd in: (2016-05-01)

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
door: Pasquale Niscola
Gepubliceerd in: (2014-08-01)

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia
door: Mathieu Meunier, et al.
Gepubliceerd in: (2022-11-01)

The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
door: Hassan Awada, et al.
Gepubliceerd in: (2020-11-01)

Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
door: Kevin Yao, et al.
Gepubliceerd in: (2023-03-01)

Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)
door: Tomohiro Horio, et al.
Gepubliceerd in: (2020-11-01)

Síndrome mielodisplásica secundária à quimio ou radioterapia: SMD relacionada a tratamento Myelodysplastic syndrome secondary to chemo: and radiotherapy MDS related to the treatment
door: Ronald F. Pinheiro, et al.
Gepubliceerd in: (2006-09-01)

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
door: Raza Azra, et al.
Gepubliceerd in: (2012-04-01)

657del5 mutation of the NBS1 gene in myelodysplastic syndrome
door: Bunjevacki Vera, et al.
Gepubliceerd in: (2014-01-01)

A rare case of myelodysplastic syndrome with refractory thrombocytopenia
door: Waqas Jehangir, et al.
Gepubliceerd in: (2015-09-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
door: Namik Özbek, et al.
Gepubliceerd in: (2015-02-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
door: Ziqi Wan, et al.
Gepubliceerd in: (2020-10-01)

Management of Adult Patients with Myelodysplastic Syndromes
door: Nicolas Bonadies
Gepubliceerd in: (2017-08-01)

Summary of animal models of myelodysplastic syndrome
door: Weisha Li, et al.
Gepubliceerd in: (2021-03-01)

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms
door: Ting‐juan Zhang, et al.
Gepubliceerd in: (2020-06-01)

Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
door: Hiroyoshi Kunimoto, et al.
Gepubliceerd in: (2024-12-01)

Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
door: IOANNIS KOTSIANIDIS
Gepubliceerd in: (2019-06-01)

Myeloid neoplasms with isolated isochromosome 17q: a yet to be defined entity
door: Eleftheria Lamprianidou, et al.
Gepubliceerd in: (2017-11-01)

HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
door: Mazyar Shadman, et al.
Gepubliceerd in: (2014-09-01)

Keberlanjutan Perkebunan Karet Rakyat Di Kabupaten Ketapang Kalimantan Barat
door: Martha Sari, et al.
Gepubliceerd in: (2022-10-01)

A complete 24-arc in PG(2,29) with the automorphism group PSL(2,7)
door: J.M. CHAO, et al.
Gepubliceerd in: (1996-09-01)

Análise da Morfologia de Modelos Digitais de Superfície Gerados por VANT
door: Danilo Marques Magalhães, et al.
Gepubliceerd in: (2021-06-01)

KEBERLANJUTAN RANTAI PASOK INDUSTRI KECIL DAN MENENGAH (IKM) ALAS KAKI DI KABUPATEN DAN KOTA BOGOR
door: Wilda Sukmawati, et al.
Gepubliceerd in: (2020-04-01)

Myelodysplastic syndrome and immunotherapy novel to next in-line treatments
door: Katherine Linder, et al.
Gepubliceerd in: (2021-08-01)

Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
door: Xinyu Guo, et al.
Gepubliceerd in: (2023-09-01)

Editorial: MDS: new scientific and clinical developments
door: Sabine Blum, et al.
Gepubliceerd in: (2025-02-01)

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab
door: Fadi Haddad, et al.
Gepubliceerd in: (2021-05-01)

Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
door: Anna Stein, et al.
Gepubliceerd in: (2022-03-01)

Utility of a Single-Tube, Six-Color Flow Cytometry Panel for the Diagnosis of Myelodysplastic Syndrome: Experience of a Tertiary Care Centre in India
door: R. Gupta, et al.
Gepubliceerd in: (2018-01-01)

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
door: Lisa Pleyer, et al.
Gepubliceerd in: (2016-04-01)

The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome
door: Satoko Oka, et al.
Gepubliceerd in: (2020-01-01)